A GENOTYPIC STUDY OF SEN VIRUS INFECTION IN HEALTHY BLOOD DONORS AND THALASSEMIA PATIENTS: WITH OR WITHOUT HCV INFECTION AND ITS CLINICAL IMPORTANCE

  • Bashar M Khazaal MSc Student in Department of Microbiology, College of Medicine, Al-Mustansiriyah University
  • Arwah M Al-hambani Lecturer, Department of Microbiology, College of Medicine, Al-Mustansiriyah University.
  • Ashana A Faeq Head of Molecular biology department / Central Public Health Laboratory (CPHL). Iraq, Baghdad

Abstract

Background: SEN-Virus (SEN-V-D and SEN-V-H) is a DNA virus which associated with acute post transfusion hepatitis and blood transfusion is the most common mode of transmission of this virus like HCV, HBV and HIV among population. Beta thalassemia is a disease need continuous blood transfusions to manage the patient’s life; so these patients are at increased risk of infection with SEN-V. Aims of this study: This study was designed to search the prevalence of SEN-V among thalassemia patients and blood donors and to evaluate the clinical importance of SEN-Virus in thalassemia patients with or without HCV infection in Iraq and to detect the exact genomic characterization of SEN-V-D and SEN-V-H genotypes in Iraq and study of similarity of these genomes with other countries especially the neighboring countries and the homology between each isolate. Methods: One hundred and fifty eight thalassemia patients (57.6% male, 42.4% female), with mean age of 16.8±8.5 year, and one hundred and fifty healthy blood donors with randomly selected persons (58.7%male, 41.3% female), with mean age of 16.7±8.6 year; all these samples involved in this study. SEN-V and HCV had been identified by nested conventional PCR. Liver transaminases (Aspartate Transaminase and Alanine Transaminase) had been determined, in addition of measure of serum ferritin levels by VIDAS. Gene sequencing and phylogenetic analysis had been studied of randomly selected amplified SEN-V D and H DNA samples. Results: SEN-V was detected in 68 from 158 (43%) of thalassemia patients and 16 from 150 (10.7%) of blood donors. HCV prevalence was (11.4%) in thalassemia patients. There was significant increase in prevalence of SEN-V or HCV infection with age but there was no significant difference in prevalence in both with gender. SEN-V and HCV co-infection significantly increases AST level above normal range. SEN-V significantly increases ALT level above normal range and has a great significant ALT level increase with HCV co-infection. Serum ferritin has no significant relation with SEN-V or SEN-V and HCV co-infection. The results from the study of gene sequencing and phylogenetic analysis of samples of amplified SEN-V-D DNA and samples of amplified SEN-V-H DNA that selected randomly from blood donors and thalassemia patients infected with D or H genotypes alone or together (co-infection) were concluded that the most transmission route of SEN-V D and H was blood transfusion, because there was (99%) gene similarity between blood donors and thalassemia patients, furthermore SEN-V-D or SEN-V-H sequences of the co-infected persons are the same sequences of D or H genotypes alone with the observations of similarity with other neighboring countries. Conclusion: SEN-V (D & H) can be transmitted via blood transfusion and cause acute hepatitis with or without HCV co-infection. The most countries had similar sequences to Iraqi SEN-V-D genotype sequence are Iran, USA and Brazil; while the most countries have similar sequences to Iraqi SEN-V-H genotype sequence are China and Iran. SEN-V-D or SEN-V-H sequences of the co-infected persons are the same sequences of D genotype or H genotype of persons that have infection with SEN-V-D or H alone.

Author Biographies

Bashar M Khazaal, MSc Student in Department of Microbiology, College of Medicine, Al-Mustansiriyah University
MSc Student in Department of Microbiology, College of Medicine, Al-Mustansiriyah University
Arwah M Al-hambani, Lecturer, Department of Microbiology, College of Medicine, Al-Mustansiriyah University.
Lecturer, Department of Microbiology, College of Medicine, Al-Mustansiriyah University.
Ashana A Faeq, Head of Molecular biology department / Central Public Health Laboratory (CPHL). Iraq, Baghdad
Head of Molecular biology department / Central Public Health Laboratory (CPHL). Iraq, Baghdad

References

Nelson, W. E., Behrman, R. E., Kliegman, R. M., Avin, A. M. (2000). Nelson’s textbook of pediatrics. 16th Ed. Pp: 11401-4.

Ghodekar, S., Grampurohit, N., Kadam, S., & Thorat, R. (2010). Thalassemia: a review. International journal of pharma research and development; 2(10):101-108.

Allain, J. P. (2000). Emerging viruses in blood transfusion. Vox Sanguinis, vol. 78(suppl. 2):243-248.

Kamahora. T., Hino, S., & Miyata, H. (2000). Three spliced mRNAs of TT virus transcribed from a plasmid containing the entire genome in COS1 cells. J Virol 74:9980–9986.

International Committee on Taxonomy of Viruses (ICTV) dB Index of viruses. (2002) http://ictvdb.bio-mirror.cn/Ictv/fr-index.htm

Fiordalsi, G., Boneli, M., Olivero, P., Prim, D., Vaglin, L., Diasorn, S. R. L., Matiol, S., Boneli, F., DalCors, A., Mantero, G., Giovani, L., Sotin, A. (2000). Identification of SEN-V genotypes. Italian patent WO19EP0856 (WO02839).

Okamoto, H., Nishizawa, T., Kato, N., Ukita, M., Ikeda, H., Iizuka, H., Miyakawa, Y., & Mayumi, M. (1998). Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology Hepatol. Res. 10: 1-16.

Umemura, T., Yeo, A. E., Sottini, A., Moratto, D., Tnaka, Y., Wang, P. Y., Shin, J. W., Donahue, P., Primi, D., & Alter, H. G. (2001). SEN-V infection and its relationship to transfusion-associated hepatitis. Hepatology33, 1303-1311.

Yoshida, E. M., Buczkowski, A. K., Giulivi, A., Zou, S., & Forrester, L. A. (2001). A cross-sectional study of SEN-V in liver transplant reciepents. Liver transplant. 7, 5211-525.

Hassanahahi, G., Kazemi, A. M., Assar, S. (2011). Post-transfusion-transmitted hepatitis C virus infection: a study on thalassemia and hemodialysis patients in southeastern Iran. Arch. Virol. 156:1111-1115.

Yaish, H. M. (2010). “thalassemiaâ€, available at www.medicine.com, accessed on July.

Prati, D., Zanella, A., Farma, E., De, Mattei C., Bosoni, P., Zappa, M., Picone, A., Mozzi, F., Rebulla, P., Cappellini, M. D., Allain, J. P., & Sirchia, G. (1998). A multicenter prospective study on the risk of acquiring liver disease in anti-HCV negative patients affected from homozygous b-thalassemia. Blood 92:3460.

Sagir, A., Kirschberg, O., Heintges, T., Erhardt, A., & Haussinger, D. (2004). SEN virus infection. Rev Med Virol. 2004;14(3):141-8.

Abbas Karimi-Rastehkenari & Majid Bouzari (2010). High frequency of SEN virus infection in thalassemic patients and healthy blood donors in Iran. Virology Journal 2010, 7:1.

Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, Shinn-Cherng Chen, Ming-Hsing Sung & Ming-Yen Hsieh (2004). SEN virus infection among patients on maintenance hemodialysis in southern Taiwan. The Journal of infection (Impact Factor: 4.44). 08/2005; 51(2):110-5.

Bouzari, M. & Hosseini, S.A. Frequency of SENV Virus in healthy, hepatitis B and C infected individuals in Yazd province, Iran. Submitted (27-SEP-2013) Contact: Majid Bouzari University of Isfahan, Faculty of science, Department of Biology; Hezar-Jreeb street, Isfahan, Isfahan 81746-73441, Iran.

Umemura, T., Tanaka, Y., Kiyosawa, K., Alter, H. J. and Shih, J. W. (2002). Observation of positive selection within hypervariable regions of a newly identified DNA virus (SEN virus) FEBS Lett. 510 (3), 171-174.

Diniz-Mendes, L., Devalle, S., and Niel, C. (2003). Genomic Characterization of a Brazilian TT Virus Isolate Closely Related to SEN Virus-f. Submitted (24-OCT-2003) Virology, Oswaldo Cruz Institute, Av.Brazil, 4365, Rio de Janeiro, RJ 21045-900, Brazil.

Du, J., Wang, Q. L. and Li, Y. (2004). Prevalence of a newly identified SEN virus in China. World J Gastroenterol, 10(16):2402-2405.

Published
2016-10-30
How to Cite
Khazaal, B. M., Al-hambani, A. M., & Faeq, A. A. (2016). A GENOTYPIC STUDY OF SEN VIRUS INFECTION IN HEALTHY BLOOD DONORS AND THALASSEMIA PATIENTS: WITH OR WITHOUT HCV INFECTION AND ITS CLINICAL IMPORTANCE. Mintage Journal of Pharmaceutical and Medical Sciences (ISSN: 2320-3315), 24-32. Retrieved from http://mjpms.in/index.php/mjpms/article/view/105